Health ❯ Healthcare ❯ Medications

Weight Loss

Mounjaro GLP-1 Drugs GLP-1 Agonists GLP-1 GLP-1 Receptor Agonists Wegovy Orforglipron Ozempic Tirzepatide Semaglutide

GLP-1 Weight-Loss Boom Is Reshaping Diets as Experts Urge Lifestyle Support

Food companies report falling sugar demand with the spread of Ozempic-class drugs.

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

WHO-Backed Reviews Affirm GLP-1 Weight-Loss Gains as Clinicians Flag Safety and Nutrition Gaps

Trump Launches TrumpRx.gov With Discounts on More Than 40 Medicines, Including GLP-1 Drugs

The Beauty Debuts on FX, Hulu and Disney+ With Big Buzz and Divided Reviews

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Liraglutide Patent Expiry Triggers Cheaper Weight‑Loss Generics in Germany

Wegovy Pill Posts Strong U.S. Debut as U.K. Authorizes Higher 7.2 mg Injectable Dose

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Tom Brady Joins eMed as Founding Chief Wellness Officer and Board Member

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

Stopping Mounjaro Leads to Weight Regain and Reversed Health Gains, Study Finds

Robbie Williams Says His Vision Is Deteriorating, Blames Mounjaro

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing

Over Half of Wegovy Starters Stop Within a Year, Danish Registry Shows

Study Finds One in Five Ozempic, Wegovy, Mounjaro Users Report Taste Changes

Confusion Over GLP-1 Weight-Loss Jabs Puts UK Insurance Cover at Risk

UK Weight-Loss Drug Access Squeezed by Mounjaro Price Hike as Lilly Points to 2026 Pill